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An inducible promoter system provides a powerful tool for studying the genetic basis for virulence. A variety
of inducible systems have been used in other organisms, including pXyl-xylR-inducible promoter, the pSpaclacI system, and the arabinose-inducible PBAD promoter, but each of these systems has limitations in its
application to Staphylococcus aureus. In this study, we demonstrated the efficacy of a tetracycline-inducible
promoter system in inducing gene expression in S. aureus in vitro and inside epithelial cells as well as in an
animal model of infection. Using the xyl/tetO promoter::gfpuvr fusion carried on a shuttle plasmid, we demonstrated that dose-dependant tetracycline induction, as measured by bacterial fluorescence, occurred in each of
the above environments while basal activation under noninduced conditions remained low. To ascertain how
the system can be used to elucidate the genetic basis of a pathogenic phenotype, we cloned the sigB gene
downstream of the inducible promoter. Induction of SigB expression led to dose-dependent attachment of the
tested strain to polystyrene microtiter wells. Additionally, bacterial microcolony formation, an event preceding
mature biofilm formation, also increased with tetracycline induction of SigB.
Staphylococcus aureus is an important human pathogen that
causes a variety of serious infections, including pneumonia,
endocarditis, and sepsis (2). The recent emergence of vancomycin-resistant S. aureus strains has highlighted the need to
identify potential targets for the development of novel antimicrobial therapies. Prime among these are virulence factors that
contribute to pathogenesis. The evaluation of virulence genes
in S. aureus has traditionally been conducted via gene knockout methods followed by complementation, often with a multicopy plasmid that overexpresses the gene product constitutively. An improvement to this method for assaying gene
function is to induce gene expression with an inducible promoter system. Using such a system, gene expression can be
titrated and the corresponding phenotype analyzed. Accordingly, more quantitative data on the role of a particular gene
product in pathogenesis can be obtained.
A number of inducible promoter systems have been considered for use in S. aureus. These include the pXyl-xylR-inducible
promoter (13) and the pSpac-lacI system (21) in Bacillus subtilis and the arabinose-inducible PBAD promoter from Escherichia coli (8). In exploring these promoters as tools to evaluate
pathogenesis in S. aureus, each of these systems displayed
major deficiencies that prevented their deployment. For instance, the xylose-inducible promoter system is repressible by
glucose, a common constituent inside mammalian cells, thus
prohibiting its use in in vivo studies. This repression cannot be
readily relieved by a higher concentration of xylose, even in
medium with low glucose concentration (unpublished data).
The pSpac/lacI system was also not readily adaptable to S.
aureus due, in part, to its high basal promoter activity (unpub-

lished data). Additionally, induction with IPTG (isopropylthiogalactopyranoside) for the pSpac promoter renders this system
less attractive in an animal model system. Finally, the arabinose-inducible PBAD promoter has not been proven useful in
S. aureus, probably due to poor penetration of arabinose into
staphylococci.
The tetracycline-inducible promoter system, first described
in E. coli and B. subtilis (7), was recently adapted to S. aureus
(11, 22). This system appears to be useful for investigating the
contribution of virulence genes to S. aureus pathogenesis both
in vitro and in vivo. Using the reporter gene gfpuvr cloned
downstream of the xyl/tetO promoter, we report here successful
and dose-dependent tetracycline induction in three different
experimental conditions, including in vitro growth, bacteria
within epithelial cells, and a murine airpouch model. With this
expression system, we also demonstrated the role of the alternative transcription factor B (14, 20) in mediating microcolony formation, a prerequisite step for mature biofilm formation. Taken together, these data suggest that the tetracyclineinducible promoter system is a powerful tool, both in vitro and
in vivo, for investigating the contribution of virulence genes in
the pathogenesis of S. aureus infections.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth medium. The bacterial strains and
plasmids used in this study are listed in Table 1. TSB (tryptic soy broth) was used
to grow S. aureus strains, while LB (Luria-Bertani) was used for E. coli. Chloramphenicol was used at 10 g/ml and ampicillin at 50 g/ml.
Genetic manipulations in E. coli and S. aureus. All restriction enzymes were
acquired from Gibco-BRL Scientific (Coon Rapids, Minn.). An 800-bp fragment
comprising the tetR gene (encoding the TetR repressor) and the xyl/tetO promoter was cleaved from pWH353 (7) and cloned into the PstI and SmaI sites of
shuttle plasmid pSK236. Correct insertion into the recombinant plasmid was
confirmed by restriction mapping and sequencing. This construct was designated
pALC2073.
To test the activity of the inducible promoter system, we constructed a plasmid
in which the inducible xyl/tetO promoter drives the expression of the green
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TABLE 1. Strains and plasmids used in this study
Strain or
plasmid

Reference

S. aureus
RN6390

17

RN4220

17

ALC1001
ALC1497

3
3

ALC2158
ALC2085

This study
This study

ALC2109

This study

E. coli
XL-1 Blue
TOP10F⬘
Plasmids
pCR2.1
pSK236

Invitrogen
Invitrogen
6

pWH353

7

pALC2073

This study

pALC2084

This study

pALC2109

This study

Description

Laboratory strain that maintains
its hemolytic pattern when
propagated on sheep
erythrocytes and has a genetic
background similar to that of
8325-4
Mutant of 8325-4 that accepts
foreign DNA
sigB mutant of RN6390
ALC1001 complemented with
shuttle plasmid pALC1496
(with the sigB gene)
RN6390 containing pALC2073
RN6390 containing pALC2084
(pALC2073::gfpuvr)
RN6390 containing
pALC2073::sigB
Cloning strain
Strain for cloning PCR fragments
PCR cloning vector
S. aureus-E. coli shuttle vector
with pUC19 cloned into the
HindIII site of pC194
Plasmid carrying an 800-bp
fragment comprising the tetR
gene (encoding the TetR
repressor) and the xyl/tetO
promoter
pSK236 containing the tetR gene
and the xyl/tetO promoter that
were cleaved from pWH353
and cloned into the PstI and
SmaI sites
pALC2073 with gfpuvr cloned into
the EcoRI site
pALC2073 with sigB cloned into
the EcoRI site

florescent protein gene, gfpuvr. The gfpuvr gene was constructed by introducing an
S65T mutation into gfpuv (Clontech, Palo Alto, Calif.), effecting a shift in the
excitation maximum from 395 to 488 nm. This gene, gfpuvr, was cloned into the
EcoRI site downstream from the inducible promoter in pALC2073. The correct
insertion was determined by restriction mapping and sequencing. The recombinant plasmid was first electroporated into RN4220 and then finally into RN6390,
as described (19).
To construct a plasmid containing sigB downstream from the inducible promoter, the sigB gene was first amplified by PCR using chromosomal DNA from
strain RN6390 as the template. The following primer pairs were used for the
amplification: 5⬘-GCTCTAGAGGGAGGTTTTAAACATGGCGAAAGAGTC
GAAATCAGCT-3⬘ and 5⬘-ACGCGTCGACCTATTGATGTGCTGCTTCTT
G-3⬘, with the XbaI and SalI sites in italic. The PCR product was ligated into
pCR2.1 (Invitrogen, Carlsbad, Calif.). The sigB gene in pCR2.1 was cleaved and
cloned downstream of the tetracycline-inducible promoter in pALC2073 at the
EcoRI site. Correct orientation of the insert was confirmed by restriction mapping and sequencing. This plasmid was electroporated into RN4220 and then
into RN6390 (19).
Analysis of tetracycline-inducible promoter in vitro. RN6390 containing
pALC2073 (ALC2158) and pALC2084 (pALC2073::gfpuvr) (ALC2085) were
grown overnight in TSB with chloramphenicol. The bacteria were then diluted
1:100 in TSB containing chloramphenicol and further cultured at 37°C with
shaking (225 rpm) to an optical density at 650 nm (OD650) of 0.5. Tetracycline
was then added at various concentrations (range, 0 to 500 ng/ml) that represented subinhibitory concentrations. The bacteria were sampled hourly (100 l)

in triplicate and analyzed in microtiter wells for fluorescence and OD650 simultaneously, using a multipurpose fluorescence spectrophotometer (FL600;
BioTek Instruments, Winooski, Vt.). Results were reported as total fluorescence
(FL) units/OD650 unit to minimize the variation in fluorescence due to cell
densities.
Analysis of tetracycline-inducible promoter in CFT-1 epithelial cells. CFT-1
cells, an immortalized cell line derived from the tracheal epithelial cells of a
cystic fibrosis patient with a ⌬F508 mutation in the CFTR gene, were grown on
vitronectin-treated (Cohesion, Palo Alto, Calif.) coverslips (MatTek, Ashland,
Mass.) at 37°C with 5% CO2 until confluent. Cells were cultured in Dulbecco’s
modified Eagle’s medium (DMEM)/F12 medium (Mediatech, Herndon, Va.)
with 2 mM L-glutamine and 100 U of penicillin G, 100 g of streptomycin, 250
ng of amphotericin B, 10% fetal bovine serum (FBS; Sigma, St. Louis, Mo.), 10
g of insulin, 1 M hydrocortisone, 3.75 g of endothelial cell growth supplement, 25 ng of epidermal growth factor, 30 nM triiodothyronine, 5 g of transferrin, and 10 ng of cholera toxin per ml (12). Prior to the assay, monolayers were
washed three times with phosphate-buffered saline (PBS) and incubated for 1 h
in DMEM/F12 plus 5 mM L-glutamine and 1% FBS.
ALC2085 from an overnight culture of TSB containing chloramphenicol was
diluted 1:50 in similar medium and grown to OD650 of 0.6. These bacteria were
washed twice in PBS, passed through a 5-m filter to remove cellular aggregates,
and finally resuspended in PBS. Bacteria were added to CFT-1 cells at a multiplicity of infection (MOI) of 10:1 (bacteria-host cell ratio) and incubated for 2 h
at 37°C and 5% CO2. Monolayers were then washed three times with PBS to
remove unattached bacteria and incubated for 4 h at 37°C with 5% CO2 in
medium containing 200 g of gentamicin (Sigma) per ml to kill extracellular
ALC2085 or gentamicin plus tetracycline to induce gene expression. Induction of
GFP expressed by intracellular bacteria was observed with a Leica DM IRBE
microscope (Leica Microsystems, Buffalo, N.Y.) using Hamamatsu camera controller C4742-95 (Bridgewater, N.J.) and OpenLab software (Improvision, Lexington, Mass.).
Analysis of tetracycline-inducible promoter in murine airpouch model. To
assess the utility of the tetracycline-inducible promoter system in vivo, we employed a murine airpouch model in which ALC2085 was used to colonize or
infect a subcutaneous airpouch. To create the airpouch, 5 ml of air in a 5-ml
syringe was injected intradermally with a 26-gauge needle on the posterior side
of the mouse. Three days later, the airpouch was reenforced by an additional
injection of 2.5 ml of air into the same pocket. After 3 more days, 108 CFU of S.
aureus strain ALC2085(pALC2084) was inoculated into the airpouch. To induce
gene expression, 100 g of tetracycline was injected introperitoneally immediately following infection and subsequently every 12 h for 48 h. This amount of
tetracycline has been titrated for expression in pilot studies. PBS injection was
used as the control. Twelve hours after the last tetracycline injection, the airpouch was lavaged with 1 ml of PBS (pH 7.4). The aspirant was then diluted
1:100 in sterile PBS and analyzed for the population of fluorescent bacteria with
a FACScan (Becton Dickinson, Franklin Lakes, N.J.).
Preparation of cell extracts for SigB detection by Western blot. RN6390,
carrying the plasmid containing the tetracycline-inducible promoter that drives
the expression of sigB (ALC2109) and the vector control (ALC2158), was grown
in a 25-ml culture overnight in various concentrations of tetracycline. Following
pelleting, the cells were resuspended in 1 ml of TEG buffer (25 mM Tris, 5 mM
EGTA, pH 8), and cell extracts were prepared using lysostaphin (AMBI, Purchase, N.Y.) as described (4). Cell extracts were then calibrated for total cellular
proteins, and 50 g of each sample was loaded on a sodium dodecyl sulfate–12%
polyacrylamide gel electrophoresis (SDS-PAGE) gel, electrophoresed, and immunoblotted onto nitrocellulose as described (1).
To detect B, anti-B monoclonal antibody 1D1 diluted 1:1,000 was allowed to
incubate with the immunoblot for 3 h. The blot was then washed and incubated
with affinity-purified goat anti-mouse immunoglobulin antibody conjugated to
alkaline phosphatase (Jackson ImmunoResearch, West Grove, Pa.) at a 1:10,000
dilution. Reactive bands were then detected with developing substrates as described (1). The intensities of the reactive bands were quantitated by densitometric analysis, using SigmaGel software (Jandel Scientific, San Rafael, Calif.).
Microcolony formation and adherence assays. S. aureus strains analyzed for
bacterial aggregation and microcolony formation were inoculated in TSB and
grown at 37°C to an OD650 of 1.1. The bacteria were then diluted 1:100 in TSB
with appropriate antibiotics (including increasing amounts of tetracycline when
induction was desired), and 100 l of each mixture was then added to the well of
a polystyrene 96-well tissue culture plate (Corning, Corning, N.Y.). The bacteria
were then grown at 37°C for 24 h without shaking. To assess microcolony
formation, microscopy was used to examine intercellular aggregation upon induction of B with tetracycline, using the 10⫻ objective of a Leica DM IRBE
microscope.
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RESULTS

FIG. 1. Induction of the xyl/tetO promoter linked to the gfpuvr reporter with increasing concentrations of tetracycline in strain
ALC2085. Following overnight culture, the cells were diluted 1:100 in
fresh TSB and then grown to an OD650 of 0.5. Tetracycline was then
added to the final concentrations shown above. The cells were sampled
hourly following induction (100 l each, in triplicate). Fluorescence
and OD650 measurements were obtained using a multipurpose spectrophotometer (FL600; Biotek Instrument). Results are presented as
reported fluorescence (FL) units/OD650 to account for variations in
fluorescence due to cell density. Data are given as the mean of the
triplicate measurements. Error bars are too small to be shown. The
experiment was repeated twice, with one representative experiment
shown.

To quantitate bacterial adherence, a prelude to mature biofilm formation,
nonadherent bacteria from overnight cultures were removed from the microtiter
wells with gentle suction. The wells were then washed three times with distilled
water and air dried for 10 min. Attached bacteria were stained with 150 l of
0.04% safranin O solution (in 20% ethanol). Staining was allowed to proceed for
10 min, after which the plate was washed four times with water and dried. For
quantitation, 100 l of 30% acetic acid was added to each well to dissolve the
stain. The OD405 of the dissolved stain was then measured in a multipurpose
enzyme-linked immunosorbent assay (ELISA) reader (FL600).

Functionality of tetracycline-inducible promoter in vitro. To
test the inducible promoter in vitro and to ascertain the optimal concentration of tetracycline for induction, we used the
gfpuvr reporter gene that we have cloned downstream of the
inducible promoter in recombinant shuttle plasmid pALC2058.
The promoter activity in strain RN6390 was then analyzed by
measuring bacterial fluorescence as an indicator of GFPuvr
expression. Our data revealed dose-dependant induction of the
xyl/tetO promoter, with maximum induction at a tetracycline
concentration of 250 ng/ml (Fig. 1). At tetracycline concentrations exceeding this value (e.g., 500 ng/ml), growth retardation
occurred, corresponding to a decrease in promoter activity due
to lower cell number. Importantly, we were not able to detect
the activity of the promoter under noninduced conditions during the entire time course of this experiment (5 h), as indicated
by the relatively flat FL/OD650 response of ALC2085 in the
absence of tetracycline, similar to RN6390 containing the vector control when grown under identical conditions (data not
shown).
Functionality of inducible promoter inside CFT-1 epithelial
cells. To determine the tetracycline inducibility of the xyl/tetO
promoter of pALC2084 inside epithelial cells, we incubated S.
aureus strain ALC2085 (RN6390 with pALC2084) with CFT-1
cells (see Materials and Methods) followed by treatment with
medium containing gentamicin (to kill extracellular S. aureus)
in the presence and absence of tetracycline for 4 h. In previous
studies, we have shown that internalization of live S. aureus by
CFT-1 cells occurred efficiently with this method (12). Following internalization, monolayers of CFT-1 cells containing intracellular ALC2085 were examined by fluorescent microscopy
for GFP expression. As shown in Fig. 2, tetracycline was accessible to the intracellular compartment containing ALC2085
and able to induce the expression of GFP at concentrations
ranging from 125 to 250 ng/ml, while no GFP expression was
detected in the absence of tetracycline.
Functionality of inducible promoter in murine airpouch
model. To evaluate the utility of the tetracycline-inducible promoter in vivo, we employed a murine airpouch model. Following the creation of an airpouch, mice were infected with

FIG. 2. Tetracycline-induced GFP expression of ALC2085 inside CFT-1 epithelial cells. ALC2085, grown to an OD650 of 0.6, was added to
CFT-1 monolayers at an MOI of 10:1 for 2 h. Extracellular bacteria were removed by washing followed by the addition of gentamicin (200 g/ml)
for 4 h to kill any remaining extracellular microorganisms. Tetracycline was added to some wells to facilitate induction. Cells were then examined
by fluorescence microscopy. Most of the bacteria were intracellular, as evidenced by the failure of these bacteria to stain with anti-protein A
antibody conjugated to Texas Red (data not shown). The experiment was repeated twice, with one representative experiment shown. Upon
tetracycline induction of the xyl/tetO promoter of intracellular bacteria driving the expression of GFP, green fluorescence was observed only in
tissue culture wells containing tetracycline.
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FIG. 3. Flow cytometry of lavaged bacteria obtained from the murine airpouch. An airpouch was created on the posterior side of the mouse.
ALC2085 (RN6390 with a plasmid carrying the inducible promoter driving gfpuvr) was injected into the airpouch at 108 CFU. Tetracycline (100
g) or a PBS injection was given every 12 h for 48 h. At 12 h after the final injection, the airpouch was lavaged with 1 ml of PBS. The aspirant
was then diluted 1:1,000 in PBS (pH 7.4) and analyzed on a FACScan (Becton Dickinson). Ten thousand events were detected by forward scatter
and a histogram was generated, showing the number of counts as a function of fluorescence. The experiment was repeated with two mice, with one
representative experiment shown.

ALC2085 at 108 CFU. Subsequently, the mice were each given
an IP injection of 100 g of tetracycline or PBS every 12 h for
48 h. The airpouch was lavaged 12 h after the last IP injection,
and the lavage fluid was analyzed with a FACScan (Becton
Dickinson). Ten thousand events were acquired for each sample and counts of detected events were plotted as a function of
fluorescence. As shown in Fig. 3, a higher proportion of fluorescent bacteria were detected under the induced condition
compared with the noninduced control.
Employment of tetracycline-inducible system to demonstrate the role of B in attachment and microcolony formation. To demonstrate how the inducible promoter system
might be used to explore the regulation of a pathogenic phenotype, we examined SigB under inducible conditions in an
attempt to study its role in biofilm formation. For this purpose,
we cloned a ribosome-binding site together with the coding
region of sigB downstream of the inducible promoter in shuttle
plasmid pALC2073. The recombinant plasmid pALC2109 was
electroporated into RN4220 and then into RN6390 (see Materials and Methods), a strain that is partially deficient (not
absent [unpublished data]) in B expression due to an 11-bp
deletion in rsbU.
To ensure that the RN6390 clone carrying pALC2109 was
synthesizing B in a dose-dependent manner upon induction,
the strain was grown in various amounts of tetracycline in
overnight cultures from which cell extracts were prepared, and
50 g of total protein from each extract was run on an SDS gel
and immunoblotted. The blot was probed with 1D1 anti-B
monoclonal antibody at a dilution of 1:1,000, followed by an
appropriate conjugate and developing substrates. As shown in
Fig. 4, the expression of B correlated well with tetracycline
induction in a dose-dependant fashion. Densitometric analysis
revealed 719 densitometric units for the noninduced culture,

1,800 units for tetracycline induction at 50 ng/ml, and 3,297
units for induction at 150 ng/ml. As a control, we used RN6390
containing the vector pALC2073 alone (ALC2158). As anticipated from a SigB-deficient strain, SigB was also expressed
from ALC2158, but the level of expression was low (556 densitometric units for the intact Sigma and 248 units for the
degradative product); this level of expression was similar to
that of ALC2109 without induction.
Having established the induction of B expression by tetracycline in strain ALC2109, we proceeded to ascertain the effect
of B expression on staphylococcal attachment to microtiter
wells, a simulated event that mirrors early biofilm formation in
vitro (23). Bacterial attachment was assessed by staining with
safranin the adherent colonies on the bottom of the microtiter
wells with overnight cultures. The safranin stain was then solubilized by the addition of 30% acetic acid. The OD405 for
each well was then determined using a multipurpose spectrophotometer (FL600). As controls, we tested RN6390 (B deficient), ALC1001 (RN6390 with a B mutation), and ALC1497
(ALC1001 with a multicopy plasmid encoding the B operon)
(3).
Although both RN6390 and ALC1001 attached poorly,
ALC1497, a strain that hyperexpresses B, attached well. Interestingly, bacterial attachment of ALC2109 to microtiter
wells was proportional to the induction of B (Fig. 5 and 4),
with maximal adherence occurring at a tetracycline concentration of 150 ng/ml. At higher concentrations, growth was inhibited under the nonshaking and oxygen-limiting conditions of
microtiter wells.
To ensure that biofilm formation was attributable to B
induction and not a consequence of antibiotic stress, ALC2158
(RN6390 with pALC2073), a strain with just the inducible
promoter, we also tested for biofilm formation after growth in
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cedes biofilm formation (23). Following overnight growth under identical conditions as for the attachment assay, we
observed increasing microcolony formation as a result of bacterial aggregation by microscopy. As shown in Fig. 6, the size of
the autoaggregates was proportional to the B level attributable to tetracycline induction.
DISCUSSION

FIG. 4. Immunoblot of cell extracts of ALC2109 (RN6390 with a
plasmid containing the inducible promoter driving sigB) and ALC2158
(RN6390 with the vector control) as detected by anti-SigB monoclonal
antibody 1D1. The strain was grown overnight in TSB with the amount
of tetracycline indicated. Cell extracts were prepared, and 50 g of
total protein each was resolved by SDS-PAGE and blotted onto nitrocellulose. SigB protein was detected with anti-SigB monoclonal antibody 1D1 (1:1,000 dilution). The dose-dependent induction of SigB
was confirmed by densitometry of the reactive bands (see text). The
experiment was repeated twice, with one representative experiment
shown.

medium containing various amounts of tetracycline (0 to 150
ng/ml). At all tetracycline concentrations, ALC2158 failed to
produce biofilm above parental levels (data not shown).
It has been suggested that bacterial attachment and subsequent microcolony formation or bacterial aggregation pre-

In evaluating the genetic basis for virulence in S. aureus,
there is a need for an inducible promoter system that can be
employed both in vitro and in vivo. Using such a system, gene
expression can be titrated and the corresponding phenotype
analyzed, thereby providing insights into the pathogenesis of
specific genes. We have previously attempted to deploy a number of inducible systems in S. aureus, including pXyl-xylR,
pSpac-lacI, and PBAD, and found each of them to have major
deficiencies. In contrast, the tetracycline-inducible system, consisting of the tetR gene (encoding the TetR repressor) and the
xyl/tetO promoter, has proven to be highly useful for evaluating
S. aureus gene expression in vitro and in vivo, including those
found in cultured epithelial cells and in an animal model of
infection.
The tetracycline-inducible promoter system possesses several characteristics that make it ideally suited for genetic studies in S. aureus. First, the basal level of expression of the
promoter is extremely low, as evidenced by the failure of the
strain carrying the inducible promoter-gfpuvr construct to fluoresce above background levels under noninducing conditions.

FIG. 5. Bacterial attachment to polystyrene microtiter wells. Cells were grown in TSB for 24 h in a 96-well polystyrene tissue culture plate. The
plate was then washed three times gently with distilled water. The wells were stained with safranin O for 10 min, washed, and air dried. Then 100
l of 30% acetic acid was added to each well to solubilize the stain. The OD405 for each well was then determined. Each of the conditions was
replicated in eight wells. The mean OD405 values for each condition are displayed, with the error bar showing the standard deviation from the
mean.
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FIG. 6. Microcolony formation with various levels of B induction in response to increasing tetracycline concentrations. Strains were grown in
a 96-well polystyrene tissue culture plate under the same conditions used in the attachment assay (see Materials and Methods). Microscopy was
done at 10⫻ magnification. Strain RN6390 disclosed a very low level of intercellular aggregation, while the isogenic sigB mutant ALC1001 did not
exhibit any tendency toward cellular aggregation. Upon induction of B expression by increasing concentrations of tetracycline, intercellular
aggregation, as reflected by the size of the microcolony, was found to increase.

This finding allows meaningful comparison of phenotypes under induced and noninduced conditions while avoiding the
problem of leaky expression at basal levels. Second, induction
is dose dependent (Fig. 1), making it possible to titrate gene
expression to wild-type levels. This system clearly represents an
advance in the induction of gene expression over a multicopy
plasmid that provides constitutive and, at times, uncontrollable
expression. Third, a high level of promoter activity, if required,
can be achieved with this system, as evidenced by the high level
of GFPuvr production with the GFP reporter (Fig. 1), as well as
by augmented B expression achieved with the inducible promoter-sigB fusion (Fig. 4).
Besides in vitro studies, this inducible promoter system has
proven to be useful for studies of S. aureus inside epithelial
cells. There is now substantial evidence that S. aureus is internalized into human epithelial cells as well as cultured osteoblasts (9, 10, 15, 16). Indeed, it was recently shown that S.
aureus is not an innocent bystander during the internalization
process by a pulmonary epithelial cell line, but rather replicates
and induces apoptosis in host cells (12). Given that S. aureus,
as an adaptive intracellular pathogen inside epithelial cells,
may contribute toward chronicity in human infections (e.g.,
osteomyelitis and chronic abscesses), it will be essential to
identify the S. aureus genes that facilitate this pathogenic process.
We argue that the tetracycline-inducible promoter can be a
powerful tool for this purpose, because high levels of gene
induction were achievable in internalized S. aureus cells (inside
CFT-1 epithelial cells), while basal promoter activity was undetectable in the absence of tetracycline (Fig. 2). In addition to
cell cultures, we were able to show that high levels of promoter
activity can be induced in a murine airpouch model, while the
promoter remained quiescent under noninduced conditions.
We thus propose that this promoter system can be useful in

ascertaining the role of various pathogenic genes in cultured
epithelial cells as well as in animal models of infections.
As a demonstration of how the inducible promoter can be
used to probe the regulation of a pathogenic phenotype, we
examined the role of B in two key components of biofilm
formation, attachment and microcolony formation. Biofilms
are purported to play a role in the pathogenesis of persistent
infections, presumably by minimizing the exposure of the bacteria to antimicrobial agents and the host defenses (5). It has
been suggested that two antecedent but distinct events leading
to mature biofilm formation are attachment and intercellular
aggregation (23). By placing sigB under the control of the
inducible promoter on a shuttle plasmid in RN6390, we were
able to achieve titratable B expression. We found, as have
others (18), that the presence of B correlated with increased
attachment to polystyrene. More specifically, we have found
that increasing expression of SigB (Fig. 4) in response to tetracycline induction correlated with higher levels of bacterial
attachment to the polystyrene surface. Whether attachment of
staphylococcal cells to polystyrene directly mimics the early
step in mature biofilm formation is not clear. Further experiments have to be done to demonstrate if B plays a role in
regulating attachment to relevant biological surfaces (catheters
in vivo, biological tissues, etc.).
A second step in biofilm formation, recognized previously in
Staphylococcus epidermidis, is microcolony formation or intercellular aggregation (23). By microscopy, we were able to demonstrate that increased B induction correlated with the size of
bacterial autoaggregates of S. aureus grown in liquid medium.
Whether S. aureus can produce B to a high enough level to
mediate autoaggregation in vivo, as found in our in vitro studies, is not clear. Further studies are therefore needed to ascertain the significance of S. aureus microcolony formation in vivo.
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